Chimeric flavivirus enables evaluation of antibodies against dengue virus envelope protein in vitro and in vivo

Abstract In a secondary dengue virus (DENV) infection, the presence of non-neutralizing antibodies (Abs), developed during a previous infection with a different DENV serotype, is thought to worsen clinical outcomes by enhancing viral production. This phenomenon is called antibody-dependent enhanceme...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Takeshi Kurosu, Keiko Hanabara, Azusa Asai, Sabar Pambudi, Supranee Phanthanawiboon, Magot Diata Omokoko, Ken-ichiro Ono, Masayuki Saijo, Pongrama Ramasoota, Kazuyoshi Ikuta
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/d24c59de6d7345e49015206dc1b7a441
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!